$3,290,000 of ALTRIA CLIENT SERVICES LLC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"HR 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; Sections 733 and 773 regarding the regulation of tobacco HR 4213: Department of Homeland Security Appropriations Act, 2026; potential provisions related to tobacco HR 5304/S 2587: Departments of Labor, Health and Human Services and Education and Related Agencies Appropriations; potential provisions related to tobacco HR 5342/S 2354: Commerce Justice Science and Related Agencies Appropriations Act 2026; provisions related to contraband vapor products and the Organized Crime Drug Enforcement Task Forces HR 5371: Continuing Appropriations Agriculture Legislative Branch Military Construction and Veterans Affairs and Extensions Act 2026; provisions related to tobacco and nicotine S 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; provisions related to tobacco and nicotine Discussions concerning draft legislation to amend corporate tax rates Discussions concerning draft legislation on dividend tax rates Discussions regarding federal excise taxes on tobacco products Discussions concerning the full expensing of capital expenditures per the 2017 Tax Cuts & Jobs Act Implementation of Public Law 119-21 One Big Beautiful Bill Act; section 112031 related to corporate tax rates HR 1798/ S 819: End Tobacco Loopholes Act; all provisions of the bill HR 3838: Streamlining Procurement for Effective Execution and Delivery Act of 2025; provisions relating to enforcement efforts regarding illicit e-cigarettes and other unauthorized tobacco products HR 6844: Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; all provisions of the bill S 2296: National Defense Authorization Act of Fiscal Year 2025; provisions relating to enforcement efforts regarding illicit e-cigarettes and other unauthorized tobacco products S 3569: Strengthening Task Force Operations to Prevent Illicit Vaping Act; all provisions of the bill FDA-2024-N-5471, Proposed Rule regarding Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act Implementation of P.L. 117-103 Consolidated Appropriations Act, 2022; provisions related to providing FDA authority to regulate products containing synthetic nicotine Discussions related to tobacco harm reduction Discussions concerning proposals to ban characterizing flavors in tobacco products Discussions regarding the FDAs need to urgently implement a compliance and enforcement plan to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products Discussions concerning nicotine analogue products and FDAs regulatory authority over such products Discussions regarding federal excise taxes and the taxation of tobacco products"
You can find more data on corporate lobbying on Quiver Quantitative.
MO Insider Trading Activity
MO insiders have traded $MO stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $MO stock by insiders over the last 6 months:
- CHARLES N. WHITAKER (SVP, Chief HR Off. & CCO) sold 27,908 shares for an estimated $1,885,718
- ENNIS DEBRA J KELLY sold 5,790 shares for an estimated $418,317
- ELLEN R STRAHLMAN sold 2,000 shares for an estimated $145,118
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
MO Hedge Fund Activity
We have seen 1,139 institutional investors add shares of MO stock to their portfolio, and 925 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS added 13,531,844 shares (+111.4%) to their portfolio in Q1 2026, for an estimated $898,379,123
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC removed 11,236,807 shares (-17.2%) from their portfolio in Q1 2026, for an estimated $746,011,616
- BLACKROCK, INC. removed 5,061,285 shares (-3.9%) from their portfolio in Q1 2026, for an estimated $336,018,711
- GOLDMAN SACHS GROUP INC added 4,215,823 shares (+47.4%) to their portfolio in Q1 2026, for an estimated $279,888,488
- ASSENAGON ASSET MANAGEMENT S.A. added 3,511,430 shares (+3691.2%) to their portfolio in Q2 2026, for an estimated $252,647,388
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 2,762,939 shares (-23.1%) from their portfolio in Q1 2026, for an estimated $183,431,520
- ALLIANZ ASSET MANAGEMENT GMBH removed 2,408,530 shares (-32.6%) from their portfolio in Q1 2026, for an estimated $159,902,306
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
MO Analyst Ratings
Wall Street analysts have issued reports on $MO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 01/30/2026
To track analyst ratings and price targets for MO, check out Quiver Quantitative's $MO forecast page.
MO Price Targets
Multiple analysts have issued price targets for $MO recently. We have seen 5 analysts offer price targets for $MO in the last 6 months, with a median target of $70.0.
Here are some recent targets:
- Faham Baig from UBS set a target price of $79.0 on 07/07/2026
- Gaurav Jain from Barclays set a target price of $64.0 on 05/15/2026
- Simon Hales from Citigroup set a target price of $70.0 on 05/01/2026
- Lisa Lewandowski from B of A Securities set a target price of $73.0 on 04/10/2026
- Matthew Smith from Stifel set a target price of $68.0 on 01/30/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
